Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Aileron Therapeutics Inc (ALRN)

Aileron Therapeutics Inc (ALRN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 43,904
  • Shares Outstanding, K 38,177
  • Annual Sales, $ 0 K
  • Annual Income, $ -29,370 K
  • 60-Month Beta 3.72
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 3.37

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate -0.16
  • Number of Estimates 2
  • High Estimate -0.15
  • Low Estimate -0.16
  • Prior Year -0.26
  • Growth Rate Est. (year over year) +38.46%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.1000 +4.55%
on 07/02/20
1.3800 -16.67%
on 06/10/20
-0.0400 (-3.36%)
since 06/05/20
3-Month
0.3309 +247.54%
on 04/08/20
1.9900 -42.21%
on 06/01/20
+0.8350 (+265.08%)
since 04/07/20
52-Week
0.2500 +360.00%
on 03/12/20
1.9900 -42.21%
on 06/01/20
+0.4500 (+64.29%)
since 07/05/19

Most Recent Stories

More News
Aileron Therapeutics Initiates Enrollment in Schedule Optimization Part of Phase 1b/2 Study of ALRN-6924 as a Chemoprotection Agent in Small Cell Lung Cancer (SCLC) Patients Being Treated with Topotecan

-- Novel approach leverages the ability of intracellular p53 protein to induce cell cycle arrest in healthy cells to prevent severe toxicities driven by chemotherapy's off-target effects --

ALRN : 1.1500 (-0.86%)
Aileron Therapeutics Announces Closing of Public Offering of Common Stock and Exercise of Option to Purchase Additional Shares

Aileron Therapeutics (NASDAQ: ALRN) announced today the closing of its underwritten public offering of its common stock, including the exercise by the underwriter of their option to purchase an additional...

ALRN : 1.1500 (-0.86%)
Aileron Therapeutics Announces Pricing of Public Offering of Common Stock

Aileron Therapeutics (NASDAQ: ALRN) announced today the pricing of an underwritten public offering of 9,090,910 shares of its common stock at a public offering price of $1.10 per share, for aggregate gross...

ALRN : 1.1500 (-0.86%)
Aileron Therapeutics Announces Proposed Public Offering of Common Stock

Aileron Therapeutics (NASDAQ: ALRN) announced today that it has commenced an underwritten public offering of shares of its common stock. Aileron also intends to grant the underwriter a 30-day option to...

ALRN : 1.1500 (-0.86%)
The Zacks Analyst Blog Highlights: Aileron Therapeutics, Energy Focus, MicroVision, Mersana Therapeutics and CymaBay Therapeutics

The Zacks Analyst Blog Highlights: Aileron Therapeutics, Energy Focus, MicroVision, Mersana Therapeutics and CymaBay Therapeutics

CBAY : 3.44 (+1.78%)
EFOI : 5.95 (-1.16%)
MVIS : 1.4500 (-5.84%)
ALRN : 1.1500 (-0.86%)
MRSN : 23.33 (+5.04%)
Thinking about buying stock in Ovid Therapeutics, Celsion Corp, Aileron Therapeutics, Cronos Group, or Bank of America?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for OVID, CLSN, ALRN, CRON, and BAC.

ALRN : 1.1500 (-0.86%)
BAC : 23.01 (-2.75%)
CLSN : 3.80 (-1.81%)
OVID : 7.46 (+4.34%)
5 Top Stocks Up 100%+ in May With More Room to Run

Reopening of the economy, vaccine hopes and stimulus measures helped Wall Street climb north in May and squash the old adage "sell in May and go away."

MRK : 78.72 (-1.08%)
MRNA : 61.09 (+3.28%)
NVAX : 104.56 (+31.62%)
CBAY : 3.44 (+1.78%)
EFOI : 5.95 (-1.16%)
MVIS : 1.4500 (-5.84%)
ALRN : 1.1500 (-0.86%)
MRSN : 23.33 (+5.04%)
Aileron Therapeutics Announces Positive Interim Results from Phase 1b/2 Clinical Trial of ALRN-6924 for the Prevention of Topotecan-induced Toxicities During Treatment for Small Cell Lung Cancer

- - -

ALRN : 1.1500 (-0.86%)
Thinking about buying stock in PhaseBio Pharmaceuticals, Aileron Therapeutics, JetBlue Airways, Aurora Cannabis, or Remark Holdings?

ALRN : 1.1500 (-0.86%)
ACB : 12.42 (+1.97%)
Aileron Therapeutics Announces Initiation of Expansion Cohort and First Patient Enrolled into Expansion Cohort of Phase 1b/2 Study of ALRN-6924 as a Chemoprotection Agent

Aileron Therapeutics (NASDAQ:ALRN) announced today the expansion of one of the dose levels in the dose optimization part of its Phase 1b/2 clinical trial evaluating ALRN-6924 as an agent to protect patients...

ALRN : 1.1500 (-0.86%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade ALRN with:

Business Summary

Aileron Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It engages in developing and commercializing a novel class of therapeutics primarily in the United States. The companys lead product includes ALRN-6924, targets the tumor suppressor protein p53 for the treatment of a range of cancers...

See More

Key Turning Points

2nd Resistance Point 1.2033
1st Resistance Point 1.1767
Last Price 1.1500
1st Support Level 1.1267
2nd Support Level 1.1033

See More

52-Week High 1.9900
Fibonacci 61.8% 1.3253
Last Price 1.1500
Fibonacci 50% 1.1200
Fibonacci 38.2% 0.9147
52-Week Low 0.2500

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar